Effect of misoprostol for cervical ripening prior to pregnancy interruption before twelve weeks of gestation

East African Medical Journal

Volumn 76, Issue 10, 1999, Pages 552-555

  Okanlomo, K A ^a   Ngotho, D ^a   Moodley, J ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PAIN; PARITY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; TIME; TREATMENT OUTCOME; UTERINE CERVIX RIPENING;

ABORTION, INDUCED; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CERVICAL RIPENING; DOUBLE-BLIND METHOD; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; OXYTOCICS; PAIN; PARITY; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SOUTH AFRICA; TIME FACTORS; TREATMENT OUTCOME; VACUUM CURETTAGE;

EID: 0033233353     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Verkuyl, D.A. and Crowther, C. Suction vs. conventional curettage in incomplete abortion. A randomised controlled trial. S. Afr. Med. J. 1993; 83: 13-15.
2. Anthony, G.S., Fisher, J., Coutts, J.R.F. Forces required to surgical dilatation of pregnant and non pregnant human cervix. Br. J. Obstet. Gynaec. 1982; 89: 913-916.
3. Bugalho, A., Bique, C., Almeida, L. and Bergstrom, S. Application of vaginal misoprostol before cervical dilatation to facilitate first trimester pregnancy interruption. Obstet. Gynec. 1994; 83: 729-731.
4. Ficicioglu, C., Tasdemir, M. and Tasdemir, S. Effect of vaginal misoprostol application for cervical softening in pregnancy interruption before ten weeks of gestation. Acta. Obstet. Gynec. Scand. 1996; 75: 54-56.
5. El-Refaey, H, Calder, L. and Wheatley, D.N., Templeton A. Cervical pnming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet. 1994; 343: 1207-1209.
6. Ngai, S.W., Au Yeung, K.C., Lao, T., Ho P.C. Oral misoprostol versus vaginal gemeprost for cervical dilatation prior to vacuum aspiration in women in the sixth to twelfth week of gestation. Contraception. 1995; 51: 335-337.
7. Ngai, S.W., Au Yeung, K.C., Lao, T., Ho P.C. Oral misoprostal versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective study. Brit. J. Obstet. Gynaec. 1996; 103: 1120-1123.
8. Lawri, A., Penney, G. and Templeton, A. A randomised comparison of oral and vaginal misoprostol for cervical J priming before suction termination of pregnancy. Brit. J. Obstet. Gynaec. 1996; 103: 111-1119.
9. Bugalho, A., Faundes, A. and Jamisse, L. et al. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception. 1996; 53: 243-246.
10. Misoprostol and legal medical abortion (editorial). Lancet. 1991; 38: 1241-1242.
11. Ngai, S.W., Tang, O.S., Lao, T. Ho P.C., Ma H.K. Oral misoprostal versus placebo for cervical dilatation before vacuum aspiration in first trimester pregnancy. Hum. Reprod. 1995; 10: 1220-1222.
12. Shepard, T.H. Mobius syndrome after misoprostol: a possible teratogenic mechanism (letter). Lancet. 1995; 345: 780.
13. Hofmeyr, G.J., Milos, D., Nikodem, V.C., De Jager M. Limb reduction anomaly after failed misoprostol abortion. S. Afr. Med. J. 1998; 88: 535-6.
14. Meinert, C.L. Clinical trials. Design, conduct and analysis. Oxford University Press. 1986; 96-101.
15. Schultz, K.F., Grimes, D.A. and Gates, W. Measures to prevent cervical injury during suction curettage abortion. Lancet. 1983; 1: 1182-1184.
16. Ateinza, M.F., Barkman, R.T., King, T.M. Forces associated with cervical dilatation at suction abortion. New York: Raven Press. 1980; 343-54.
17. De Jonge, E.T., Pattinson, R.C., Makin, J.D. and Venter, C.P. Is ward evacuation for uncomplicated incomplete abortion under systemic analgesia safe and effective? S. Afr. Med. J. 1994; 84: 981-983.